Peptide record

TPDB92105

Cecropin B Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Toxicity modified_plain modified
35 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92105
Cecropin B
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF AI4AVP CPPsite3.0 ToxinPred 3.0
modified_plain
Yes
A 35-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
35 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antibacterial Activity
Hyalophora Cecropia(silkmoth) Activity
Evidence Records 13 records
Evidence 1 Activity

Activity

IC50
IC50=15.5 µM
Anticancer
15.5 µM

Target

Leukemia Cancer
K-562
Blood

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50=24.8 µM
Anticancer
24.8 µM

Target

Breast Cancer
BTS-30
Breast

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 3 Activity

Activity

IC50
IC50=25.5 µM
Anticancer
25.5 µM

Target

Colon Cancer
HRT-18
Colon

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 4 Activity

Activity

IC50
IC50=>100 µM
Anticancer
>100 µM

Target

Colon Cancer
DLD-1
Colon

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 5 Activity

Activity

IC50
IC50=4.4 µM
Anticancer
4.4 µM

Target

Leukemia Cancer
WEHI-3B
Blood

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 6 Activity

Activity

IC50
IC50=30.6 µM
Anticancer
30.6 µM

Target

Ovarian Cancer
A-2780
Ovary

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 7 Activity

Activity

IC50
IC50=33.5 µM
Anticancer
33.5 µM

Target

Colon Cancer
HCLO
Colon

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 8 Activity

Activity

IC50
IC50=32 µM
Anticancer
32 µM

Target

Ovarian Cancer
CHO-KI
Ovary

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 9 Activity

Activity

IC50
IC50=37 µM
Anticancer
37 µM

Target

Colon Cancer
MAC15A
Colon

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 10 Activity

Activity

IC50
IC50=42.5 µM
Anticancer
42.5 µM

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 11 Activity

Activity

IC50
IC50=>100 µM
Anticancer
>100 µM

Target

Colon Cancer
HT-29
Colon

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 12 Activity

Activity

IC50
IC50=34.5
Anticancer
34.5

Target

Ovarian Cancer
A-2780R
Ovary

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994
Evidence 13 Activity

Activity

IC50
IC50=24.5
Anticancer
24.5

Target

Breast Cancer
MCF-7R
Breast

Assay & Model

MTT assay
96-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
1994